Motus GI Holdings, Inc. (NASDAQ:MOTS) is expected to report third quarter earnings results, after market close, on Thursday 12th November 2020.
Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.12 per share from revenue of $ 0.02 million.
Looking ahead, the full year loss are expected at $ 0.61 per share on the revenues of $ 0.18 million.
Stock Performance
Shares of Motus GI Holdings, Inc. traded low $ -0.02 or -3.18 percent on Wednesday, reaching $ 0.74 with volume of 105.90 thousand shares. Motus GI Holdings, Inc. has traded high as $ 0.78 and has cracked $ 0.73 on the downward trend
The closing price of $ 0.74, representing a 65.22 % increase from the 52 week low of $ 0.46 and a 73.33 % decrease over the 52 week high of $ 2.85.
The company has a market capital of $ 23.82 million and is part of the Healthcare sector and Diagnostics & Research industry.
Conference Call
Motus GI Holdings, Inc. will be hosting a conference call at 4:30 PM eastern time on 12th November 2020, to discuss its 3Q20 financial results with the investment community. The participants may dial, 877-407-0792 (United States) or 201-689-8263 Outside U.S., when prompted, enter passcode 13711588 in order to access the live audio call. A live webcast with presentations will be available on the Internet by visiting the Company website www.motusgi.com
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system, a medical device, which indicates to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure.
